Centrex and Emergency Filtration Products Form Strategic Alliance.Business Editors & High Tech Writers TULSA, Okla.--(BUSINESS WIRE)--Jan. 7, 2003 Centrex, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CNEX) and Emergency Filtration Products, Inc. (EFP EFP Explosively Formed Penetrator EFP Electronic Field Production EFP Explosively Formed Projectile EFP Exempted Fishing Permit EFP Environmental Farm Planning (Canada) EFP Exempted Fishing Permits ) (OTCBB:EMFP EMFP Ethnic/Racial Minority Fellowship Programs ) today announced that they have entered into a strategic alliance to explore the marketing and distribution of their complimentary technologies. Under the terms of the alliance, both companies will focus on their individual areas of expertise while investigating potential collaborations that would serve to deliver to the marketplace complete biological filtering systems. Centrex, Inc., in conjunction with Los Alamos National Laboratory Los Alamos National Laboratory (LANL) (previously known at various times as Site Y, Los Alamos Laboratory, and Los Alamos Scientific Laboratory) is a United States Department of Energy (DOE) national laboratory, managed and operated by Los Alamos National , is developing a Bioterrorism Detection Device using Single Molecule Detection (SMD (1) (Storage Module Device) A high-performance hard disk interface used with minis and mainframes that transfers data in the 1-4 MBytes/sec range (SMD-E provides highest rate). See hard disk. ) that will be capable of detecting a variety of biological agents including smallpox and anthrax. Emergency Filtration Products' patented core 2H Technology(TM) provides filtration efficiencies of greater than 99.9 percent at a particle size of 0.027 microns. The company is exploring the use of nanotechnologies to enhance the filtration efficiencies of their core technology in a new environmental mask designed to eradicate isolated pathogens. The environmental mask is currently being tested by an independent laboratory. "We are very excited about the new strategic relationship between Centrex and EFP and believe that it positions both companies to offer the best in new technologies to combat the threat of exposure to biological agents" expressed Sherman Lazrus, EFP CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and Chairman of the Board. About Centrex, Inc. Centrex owns the exclusive worldwide license to develop, manufacture and market a system for detecting microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. contamination in air, food and water. The detection system is designed to be adaptable and easily tailored to detect a variety of bacterial and viral organisms by recognizing the unique DNA fingerprint of the organism. The proposed device is a simultaneous multi-channel detection system that is compact, fully automated and capable of monitoring the presence of biological agents in air, food and water. For further information, call Investor Relations at: 407/682-2001 or visit the Company website: www.centrexcorporation.com. About Emergency Filtration Products EFP is an air filtration products manufacturer whose patented 2H Technology(TM) provides filtration efficiencies of greater than 99.9% at a particle size of 0.027 microns. Its medical market products include: RespAide(TM), a CPR mask used for resuscitation of respiratory/cardiac arrest cases; and the 2H(TM) Breathing Circuit Filter. In addition to filtration products, the company also markets Superstat, a modified hemostatic hemostatic /he·mo·stat·ic/ (he?mo-stat´ik) 1. causing hemostasis, or an agent that so acts. 2. due to or characterized by stasis of the blood. he·mo·stat·ic adj. collagen, to military and commercial medical markets. www.emergencyfiltration.com
For Further Information on Emergency Filtration Products:
Phone (702) 558-5164
Fax (702) 567-1893
Email contactus@emergencyfiltration.com
Safe Harbor Statement: This news release contains forward-looking statements pursuant to the "Safe Harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. With the exception of historical information, the matters discussed in this news release are "forward-looking statements" that involve a number of risks and uncertainties. The actual future results of the company(s) could differ significantly from those statements. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion